文献速递主动脉外科

主动脉腔内修复术后远期失败:移植物取出指征与结局

Late failure of endovascular aortic repair: Indications for and outcomes of endograft explantation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-05-03

该单中心回顾性研究纳入1996至2025年间181例因主动脉腔内修复(EAR)远期失败行移植物取出联合开放主动脉重建(OAR)的患者,手术死亡率13.8%,5年生存率53%。移植物取出占OAR比例从1996-2005年<1%升至2016-2025年20%,提示需长期 surveillance 和谨慎选择EAR患者。

要点

  • EAR后移植物取出联合OAR手术死亡率为13.8%,5年生存率53%。
  • 移植物取出占OAR比例从<1%升至20%,以胸主动脉和腹主动脉EAR为主。
  • 遗传性主动脉病患者从EAR到取出的中位时间更短(1.4年 vs 总体2.7年)。

核心结论

  • 移植物取出联合开放主动脉重建技术难度大、风险高,尤其在移植物感染时。
  • 研究结果强调EAR后长期监测和谨慎选择患者的重要性,尤其对年轻或主动脉夹层患者。

研究设计与样本

  • 单中心回顾性研究,1996至2025年间181例因EAR远期失败行移植物取出联合OAR的患者。
  • 中位年龄65岁(IQR 53-72岁),男性占70.2%;部分取出33.7%,完全取出66.3%。
  • 既往EAR部位主要为胸主动脉(48.1%)和腹主动脉(41.4%)。

主要发现

  • 从首次EAR到取出的中位时间总体为2.7年(IQR 0.6-5.8年),遗传性主动脉病患者为1.4年(IQR 0.2-3.4年)。
  • 移植物取出占OAR比例从1996-2005年<1%(11/2150)升至2006-2015年6%(78/1214)和2016-2025年20%(92/469)。
  • 20.4%(37例)存在感染,18.8%(34例)为再次切口,61.3%(111例)行胸腹主动脉修复。
  • 手术死亡率为13.8%(25例),5年生存率为53%。

临床怎么用

  • 对EAR术后患者应进行长期监测,以便及时发现需要移植物取出的远期失败。
  • 对年轻患者或主动脉夹层患者,选择EAR时应更加谨慎。
  • 移植物取出联合OAR应在有经验的中心进行,并充分评估感染等高风险因素。

局限性

  • 本研究为单中心回顾性研究,结果可能受选择偏倚影响。
  • 原文未报告多变量分析校正后的 operative mortality 危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: As endovascular aortic repair (EAR) has become more frequent over the past 3 decades, so has the need for endograft explantation followed by open aortic reconstruction (OAR). We retrospectively examined our experience and outcomes with these procedures. METHODS: Between 1996 and 2025, 181 patients (median age 65 years [interquartile range, 53-72 years]; 70.2% male) underwent endograft explantation (33.7% partial and 66.3% complete) with OAR at our center. Previous EAR were primarily thoracic (48.1%) and abdominal (41.4%). We analyzed trends in practice, preoperative characteristics, operative details, early outcomes, and factors associated with operative mortality (death within 30 days of repair or before final hospital discharge). Survival was estimated with Kaplan-Meier and competing risk analyses. RESULTS: Median time from index EAR to explant was 2.7 years [interquartile range, 0.6-5.8 years] overall and was shorter (1.4 years [interquartile range, 0.2-3.4 years]) in patients with hereditary aortopathies. Endograft explantation increased from <1% of OAR cases (11/2150) in 1996-2005 to 6% (78/1214) in 2006-2015 to 20% (92/469) in 2016-2025. Thirty-eight patients (21.0%) were ≤50 years old, 34 (18.8%) had Marfan or Loeys-Dietz syndrome, and 74 (40.9%) had aortic dissection. Operative complexity was high: 20.4% (n = 37) had infection, 18.8% (n = 34) had a redo incision, and 61.3% (n = 111) underwent thoracoabdominal aortic repair. Operative mortality was 13.8% (n = 25). Survival was 53% at 5 years. CONCLUSIONS: Endograft explantation with OAR is technically demanding and high-risk, especially when the endograft is infected. These findings highlight the importance of long-term surveillance and careful patient selection for EAR, especially when patients are young or have aortic dissection.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Zambetti BR, Orozco-Sevilla V, Frankel WC, et al. Late failure of endovascular aortic repair: Indications for and outcomes of endograft explantation. J Thorac Cardiovasc Surg. 2026. PMID: 42086160. doi:10.1016/j.jtcvs.2026.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。